AYRO Inc (NASDAQ: AYRO) Shocks Wall Street This Week With A -1.50% Stock Price Decline
AYRO Inc (NASDAQ:AYRO) has a beta value of 3.56 and has seen 1.11 million shares traded in the recent trading session. The company, currently valued
AYRO Inc (NASDAQ:AYRO) has a beta value of 3.56 and has seen 1.11 million shares traded in the recent trading session. The company, currently valued
Newmont Corp (NYSE:NEM) has a beta value of 0.32 and has seen 5.15 million shares traded in the recent trading session. The company, currently valued
Cellectar Biosciences Inc (NASDAQ:CLRB) has a beta value of 0.53 and has seen 0.65 million shares traded in the recent trading session. The company, currently
Albemarle Corp (NYSE:ALB) has a beta value of 1.66 and has seen 0.99 million shares traded in the recent trading session. The company, currently valued
Affimed N.V (NASDAQ:AFMD) has a beta value of 1.85 and has seen 4.88 million shares traded in the recent trading session. The company, currently valued
NRX Pharmaceuticals Inc (NASDAQ:NRXP) has a beta value of 1.46 and has seen 1.35 million shares traded in the recent trading session. The company, currently
OptimizeRx Corp (NASDAQ:OPRX) has a beta value of 1.22 and has seen 0.7 million shares traded in the recent trading session. The company, currently valued
Amplify Energy Corp (NYSE:AMPY) has a beta value of 0.45 and has seen 0.49 million shares traded in the recent trading session. The company, currently
Micron Technology Inc (NASDAQ:MU) has a beta value of 1.27 and has seen 7.95 million shares traded in the recent trading session. The company, currently
Delta Air Lines, Inc (NYSE:DAL) has a beta value of 1.53 and has seen 4.63 million shares traded in the recent trading session. The company,
© 2024, Powered by Smart TechOne